Dr. Martens shares fall after flat revenue forecast for 2026

Shares in British shoemaker Dr. Martens fell by almost 12 percent on the London Stock Exchange on Tuesday. This followed the publication of a company report on the same day, signed by CEO Ije Nwokorie. He states that revenue for fiscal year 2026 will likely remain stable.